People affected by pyruvate carboxylase deficiency experience a dangerous build up of lactic acid and other potentially toxic compounds in the blood.
Pyruvate carboxylase deficiency can present in 3 different ways:
Type A (infantile form) - infants present with delayed development due to the build up of lactic acid in the blood. This can cause symptoms of vomiting, abdominal pain, extreme tiredness (fatigue), muscle weakness, and difficulty breathing. Sadly, even with treatment, most affected children die in infancy or early childhood.
Type B (severe neonatal form) - is more severe than Type A. With abies also expereincing significant brain problems including seixures and potential coma. Even with treatment, babies rarely survive to first three months of life.
Type C (intermittent/benign form) - is a milder form of the disease. People affected by Type C pyruvate carboxylase deficiency have slightly increased levels of lactic acid in the blood and minimal signs and symptoms affecting the nervous system.
As humans we have about 23,000 genes. These genes are like tiny instruction manuals that influence our health, growth and development. We inherit half of our genes from our biological mum and the other half from our biological dad. These genes are lined up on structures called chromosomes. Most of us have 23 pairs of chromosomes. The first 22 pairs are called autosomes and for the most part - these are the same among men and women. The 23rd pair determine our sex - two X chromosomes for a female and one X and one Y chromosome for males.
pyruvate carboxylase deficiency is known as an autosomal recessive condition. For autosomal recessive conditions, if a person has a variation in one copy of their gene, they are a carrier. This means that they are healthy because they also have a working copy of the gene. But, they can still pass their non-working copy to their child.
If the other parent also happens to be a carrier of the same gene, there is a 25% (1 in 4) chance that they both pass this gene variation on to their child — and as such, have a child affected by the disease.
If both parents are carriers of pyruvate carboxylase deficiency, there’s a one in four chance that their children could develop symptoms.
Carrier testing is like a checkup for your genes. It tests to see if you carry a gene variation that could cause a serious genetic disease in your child. Eugene offers an inclusive genetic carrier screening panel that includes pyruvate carboxylase deficiency, but there's a total 301 conditions that can be tested.
Eugene’s carrier test is a clinical grade test that can be done from the comfort of your own home — it’s just a saliva test. You're also paired with a genetic counsellor who provides mindful support and guidance every step of the way.Learn more about carrier screening
The biggest benefit of screening for pyruvate carboxylase deficiency is that it can help future parents understand their reproductive risk so they can be ready and empowered to make more informed decisions. If neither partner are carriers, it provides reassurance and peace of mind that the risk of having a child with a genetic disease is low.
Since 90% of children that have a recessive genetic disease like pyruvate carboxylase deficiency had no previous family history of it, it often feels completely out of the blue for the parents. Getting screened is a way to know this risk in advance, which can help familes manage or even prevent the disease in the first place.